AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
FRA Edition 
GER Edition 
ESP Edition 
ITA Edition 
NLD Edition 
PRT Edition 
SWE Edition 
GRC Edition 
IND Edition 
POL Edition 
BRA Edition 
ZAF Edition 
RUS Edition 
CHN Edition 
UAE Edition 
⚠
✓
Inari Medical Inc (NASDAQ:NARI)
-- USD
0.000 0.000%Sponsored Reports
Loading...
| Previous Close (in USD) | 79.97 |
|---|---|
| Change | 0.000 0.000% |
| 52 W H/L (in USD) | 71.850/36.730 |
| EBITDA (in USD) | -0.783M |
| PE Ratio | -- |
| Volume | -- |
| Diluted Eps TTM | -0.41 |
| Total Assets (in USD) | 674.235M |
|---|---|
| Total Liabilities (in USD) | 209.325M |
| Revenue TTM (in USD) | 520.659M |
| Cash (in USD) | 39.208M |
| Market Cap (in USD) | 2,920.863 M |
| Revenue Per Share TTM | 9.045 |
| Gross Profit TTM (in USD) | 338.965M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Inari Medical Inc
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
Employees: 1300
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. William H. Hoffman | CEO, Pres & Director | 1967 |
| 2. | Mr. Mitchell C. Hill | Chief Financial Officer | 1959 |
| 3. | Mr. Andrew J. Hykes | Chief Operating Officer | 1973 |
| 4. | Dr. Thomas M. Tu M.D. | Chief Medical Officer | 1973 |
| 5. | Ms. Janet Byk | VP of Fin. & Accounting | NA |
| 6. | Ms. Angela Ahmad | Gen. Counsel & Sec. | NA |
| 7. | Mr. Eric Khairy | Sr. VP of Marketing | NA |
| 8. | Mr. John R. Borrell | Sr. VP of Sales | 1967 |
| 9. | Ms. Dena Truelove | VP of HR | NA |
| 10. | Ms. Tara Dunn | Sr. VP of Clinical Affairs & Market Devel. | NA |
Peers
Sector: Healthcare
Industry: Medical Devices
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
ABT
Abbott Laboratories |
+0.303 0.222% | 135.78 | 37.150 | 23.148 | 4.666 | 4.975 | 4.878 | 19.381 |
|
SYK
Stryker Corporation |
+1.380 0.363% | 377.22 | 44.070 | 24.938 | 5.509 | 6.118 | 6.050 | 25.731 |
|
MDT
Medtronic PLC |
-0.314 0.355% | 88.21 | 26.600 | 15.873 | 3.354 | 2.083 | 3.897 | 14.117 |
|
BSX
Boston Scientific Corp |
+1.940 1.968% | 98.21 | 68.170 | 24.570 | 5.855 | 4.265 | 6.462 | 26.799 |
Income Statement
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Income Before Tax | -26.185M | 10.685M | 13.789M | -1.192M | -10.153M |
| Minority Interest | - | - | - | - | - |
| Net Income | -29.267M | 9.84M | 13.789M | -1.907M | -10.153M |
| Selling General Administrative | 292.843M | 190.365M | 89.746M | 37.197M | 10.698M |
| Gross Profit | 338.965M | 252.227M | 126.564M | 45.218M | 5.548M |
| Reconciled Depreciation | 7.119M | 4.308M | 1.385M | 0.614M | 0.283M |
| Ebit | -28.099M | 6.672M | 18.419M | 0.801M | -9.181M |
| Ebitda | -18.772M | 10.98M | 18.241M | 1.299M | -8.898M |
| Depreciation And Amortization | 9.327M | 4.308M | -0.178M | 0.497M | 0.283M |
| Operating Income | -28.099M | 6.672M | 18.419M | 0.801M | -9.14M |
| Other Operating Expenses | 411.57M | 266.14M | 121.251M | 50.327M | 15.969M |
| Interest Expense | 0.294M | 0.295M | 1.135M | 0.92M | 0.887M |
| Tax Provision | 3.082M | 0.845M | - | - | - |
| Interest Income | 1.852M | 0.154M | 0.484M | 0.089M | 0.092M |
| Net Interest Income | 1.558M | -0.141M | -0.651M | -0.831M | -0.795M |
| Income Tax Expense | 3.082M | 0.845M | -0.912M | 0.715M | -0.126M |
| Total Revenue | 383.471M | 276.984M | 139.67M | 51.129M | 6.829M |
| Total Operating Expenses | 367.064M | 241.383M | 108.145M | 44.417M | 14.688M |
| Cost Of Revenue | 44.506M | 24.757M | 13.106M | 5.91M | 1.281M |
| Total Other Income Expense Net | 1.914M | 4.013M | -4.63M | -1.993M | -0.218M |
| Net Income From Continuing Ops | -29.267M | 9.84M | 13.789M | -1.192M | -10.153M |
| Net Income Applicable To Common Shares | -29.267M | 9.84M | 13.789M | -1.192M | -10.153M |
Balance Sheet
(Currency in USD)| Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
|---|---|---|---|---|---|
| Total Assets | 674.235M | 504.152M | 311.542M | 214.092M | 44.547M |
| Intangible Assets | 150.884M | - | - | - | - |
| Other Current Assets | 6.481M | 5.312M | 5.694M | 2.858M | 0.514M |
| Total Liab | 209.325M | 87.15M | 72.333M | 13.838M | 83.69M |
| Total Stockholder Equity | 464.91M | 417.002M | 239.209M | 200.254M | -39.144M |
| Other Current Liab | 64.07M | 47.204M | 35.17M | 10.791M | 6.321M |
| Common Stock | 0.058M | 0.054M | 0.05M | 0.049M | 0.007M |
| Capital Stock | 0.058M | 0.054M | 0.05M | 0.049M | 0.007M |
| Retained Earnings | -48.486M | -46.85M | -17.583M | -27.423M | -41.212M |
| Good Will | 214.335M | - | - | - | - |
| Other Assets | - | 0.589M | 0.981M | 0.921M | 1.807M |
| Cash | 39.208M | 60.222M | 92.752M | 114.229M | 23.639M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 76.339M | 56.174M | 42.513M | 13.838M | 8.87M |
| Current Deferred Revenue | - | - | - | - | - |
| Net Debt | -7.161M | -27.935M | -63.546M | -114.229M | -4.159M |
| Short Term Debt | 1.692M | 1.311M | 0.802M | - | - |
| Short Long Term Debt | - | - | - | - | - |
| Short Long Term Debt Total | 32.047M | 32.287M | 29.206M | - | 19.481M |
| Other Stockholder Equity | 504.453M | 462.949M | 257.144M | 227.624M | 2.061M |
| Property Plant Equipment | - | 72.358M | 16.471M | 7.498M | 3.331M |
| Total Current Assets | 235.563M | 422.905M | 245.198M | 205.673M | 39.408M |
| Long Term Investments | - | 0M | 3.983M | - | - |
| Short Term Investments | 76.855M | 266.179M | 83.348M | 49.981M | - |
| Net Receivables | 70.119M | 58.611M | 42.351M | 28.008M | 11.302M |
| Long Term Debt | - | - | - | - | 19.481M |
| Inventory | 42.9M | 32.581M | 21.053M | 10.597M | 3.953M |
| Accounts Payable | 10.577M | 7.659M | 6.541M | 3.047M | 2.549M |
| Accumulated Other Comprehensive Income | 8.885M | 0.849M | -0.402M | 0.004M | -1.279M |
| Non Currrent Assets Other | 2.217M | 8.889M | 0.981M | 0.921M | 1.807M |
| Non Current Assets Total | 438.672M | 81.247M | 66.344M | 8.419M | 5.138M |
| Capital Lease Obligations | 32.047M | 32.287M | 29.206M | - | - |
| Long Term Debt Total | - | - | - | - | 19.481M |
Cash Flow
(Currency in USD)| Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
|---|---|---|---|---|---|
| Investments | -195.216M | -37.377M | -55.437M | -49.977M | -49.977M |
| Total Cashflows From Investing Activities | -195.216M | -51.022M | -55.437M | -3.144M | -0.753M |
| Total Cash From Financing Activities | 177.138M | 4.073M | 144.115M | 10.224M | 26.758M |
| Net Income | -29.267M | 9.84M | 13.789M | -1.192M | -10.153M |
| Change In Cash | -32.53M | -21.865M | 90.59M | 2.143M | 15.113M |
| Begin Period Cash Flow | 92.752M | 114.617M | 24.027M | 21.884M | 6.771M |
| End Period Cash Flow | 60.222M | 92.752M | 114.617M | 24.027M | 21.884M |
| Total Cash From Operating Activities | -13.972M | 25.486M | 1.912M | -4.936M | -10.892M |
| Depreciation | 7.119M | 4.308M | 1.385M | 0.614M | 0.283M |
| Other Cashflows From Investing Activities | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Change To Inventory | -11.688M | -10.488M | -6.644M | -2.874M | -0.558M |
| Sale Purchase Of Stock | 8.422M | 5.558M | 164.832M | 0.127M | 27.014M |
| Other Cashflows From Financing Activities | -5.679M | -1.485M | 10.004M | 20.364M | 26.758M |
| Capital Expenditures | 9.951M | 13.645M | 5.46M | 3.144M | 0.753M |
| Change In Working Capital | -21.468M | -14.3M | -21.169M | -6.259M | -1.52M |
| Other Non Cash Items | 0.973M | 0.143M | 0.181M | 0.101M | 0.106M |
| Free Cash Flow | -23.923M | 11.841M | -3.548M | -8.08M | -11.645M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | iShares Core S&P Small-Cap ETF | 1 year ago | 3446165 |
| 2. | Vanguard Total Stock Mkt Idx Inv | 1 year ago | 1503246 |
| 3. | iShares Russell 2000 ETF | 1 year ago | 1247809 |
| 4. | Vanguard Small Cap Index | 1 year ago | 1245533 |
| 5. | Vanguard Institutional Extnd Mkt Idx Tr | 1 year ago | 766956 |
| 6. | AB Small Cap Growth A | 1 year ago | 705967 |
| 7. | Vanguard Small Cap Growth Index Inv | 1 year ago | 703512 |
| 8. | CS (Lux) Digital Health Equity SB USD | 1 year ago | 680000 |
| 9. | American Century Small Cap Growth Inv | 1 year ago | 668713 |
| 10. | American Century U.S. Small Cap Growth | 1 year ago | 668713 |
| 11. | Baron Discovery Strategy | 1 year ago | 596078 |
| 12. | Baron Discovery Institutional | 1 year ago | 596078 |
| 13. | JPMorgan Small Cap Growth A | 1 year ago | 566112 |
| 14. | Fidelity Small Cap Index | 1 year ago | 546565 |
| 15. | Brown Advisory Small-Cap Growth Inv | 1 year ago | 526693 |
| 16. | Eventide Healthcare & Life Sciences I | 1 year ago | 512914 |
| 17. | AB Discovery Growth A | 1 year ago | 474495 |
| 18. | SPDR® Portfolio S&P 600 Sm Cap ETF | 1 year ago | 454650 |
| 19. | Alger Small Cap Focus Composite | 1 year ago | 436179 |
| 20. | iShares Russell 2000 Growth ETF | 1 year ago | 419632 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | BlackRock Inc | 1 year ago | 6696598 |
| 2. | Vanguard Group Inc | 1 year ago | 5599854 |
| 3. | Wellington Management Company LLP | 1 year ago | 4563325 |
| 4. | Franklin Resources Inc | 1 year ago | 2828075 |
| 5. | Millennium Management LLC | 1 year ago | 2314166 |
| 6. | AllianceBernstein L.P. | 1 year ago | 2213861 |
| 7. | State Street Corporation | 1 year ago | 1840961 |
| 8. | Brown Advisory Holdings Inc | 1 year ago | 1823766 |
| 9. | JPMorgan Chase & Co | 1 year ago | 1645135 |
| 10. | Credit Suisse First Boston (CSFB) | 1 year ago | 1286156 |
| 11. | Geode Capital Management, LLC | 1 year ago | 1173188 |
| 12. | Eventide Asset Management, LLC | 1 year ago | 1125000 |
| 13. | Vestal Point Capital LP | 1 year ago | 800000 |
| 14. | Morgan Stanley - Brokerage Accounts | 1 year ago | 786982 |
| 15. | BAMCO Inc | 1 year ago | 777152 |
| 16. | American Century Companies Inc | 1 year ago | 773432 |
| 17. | ING Investment Management LLC | 1 year ago | 773306 |
| 18. | Marshall Wace Asset Management Ltd | 1 year ago | 718899 |
| 19. | Dimensional Fund Advisors, Inc. | 1 year ago | 712025 |
| 20. | Northern Trust Corp | 1 year ago | 644767 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Sponsored Articles
Loading...
Related Articles
Loading...